- JP17th Edition [101MB] [March 7, 2016, the MHLW Ministerial Notification No.64]
Note: the link lead to the file on the MHLW website.- JP17th Edition texts by section (for smaller size texts)
- JP17th Edition Errata [262KB] [Issued in November 17, 2017, June 7, 2018, March 29, 2019 and April 28, 2020]
- JP 17th Edition Supplement I [4.6MB] [December 1, 2017, the MHLW Ministerial Notification No.348]
Note: the link lead to the file on the MHLW website.- JP 17th Edition Supplement I Errata [92.3KB] [Issued in April 28, 2020]
- JP 17th Edition Supplement II [2.9MB] [June 28, 2019, the MHLW Ministerial Notification No.49]
Note: the link lead to the file on the MHLW website.- JP 17th Edition Supplement II Errata [147KB] [Issued in April 28, 2020]
N.B.: The Japanese Pharmacopoeia Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia.(See the General Notices 5.)